Jacobs Levy Equity Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.1K | Sell |
27,046
-37,478
| -58% | -$117K | ﹤0.01% | 1011 |
|
|
2025
Q1 | $218K | Buy |
+64,524
| New | +$218K | ﹤0.01% | 1021 |
|
|
2021
Q4 | – | Sell |
-438,767
| Closed | -$1.15M | – | 1083 |
|
|
2021
Q3 | $1.15M | Sell |
438,767
-16,896
| -4% | -$44.4K | 0.01% | 726 |
|
|
2021
Q2 | $1.88M | Sell |
455,663
-106,006
| -19% | -$438K | 0.01% | 614 |
|
|
2021
Q1 | $2.65M | Buy |
561,669
+452,885
| +416% | +$2.13M | 0.02% | 540 |
|
|
2020
Q4 | $778K | Buy |
108,784
+25,239
| +30% | +$181K | 0.01% | 773 |
|
|
2020
Q3 | $891K | Buy |
83,545
+20,419
| +32% | +$218K | 0.01% | 685 |
|
|
2020
Q2 | $797K | Buy |
63,126
+48,225
| +324% | +$609K | 0.01% | 718 |
|
|
2020
Q1 | $136K | Buy |
14,901
+2,391
| +19% | +$21.8K | ﹤0.01% | 934 |
|
|
2019
Q4 | $175K | Sell |
12,510
-35,120
| -74% | -$491K | ﹤0.01% | 949 |
|
|
2019
Q3 | $820K | Buy |
47,630
+17,690
| +59% | +$305K | 0.01% | 647 |
|
|
2019
Q2 | $815K | Sell |
29,940
-28,205
| -49% | -$768K | 0.01% | 678 |
|
|
2019
Q1 | $1.11M | Buy |
+58,145
| New | +$1.11M | 0.02% | 633 |
|
|
2018
Q3 | – | Sell |
-13,300
| Closed | -$260K | – | 1082 |
|
|
2018
Q2 | $260K | Buy |
+13,300
| New | +$260K | ﹤0.01% | 915 |
|